You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Guidelines & Advice
About Guidelines Email Guidelines Team

Clinical Utility of Positron Emission Tomography in the Diagnosis, Staging and Management of Sarcoidosis

ID: PET 11 Aug 2011
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Authors:
J. You, B. Hyland, S. Henderson, Ontario PET Steering Committee

Guideline Objective

To summarize the current state of the science and provide potential recommendations for the use of PET in the diagnosis, staging, and clinical management of PET in sarcoidosis patients.

Patient Population

Patients with suspected or proven non-cardiac sarcoidosis.

Intended Guideline Users

To guide the Ontario PET Steering Committee in their decision making concerning indications for the use of PET imaging. This recommendation report may also be useful to inform clinical decision making regarding the appropriate role of PET imaging and to guide priorities for future PET imaging research.

Research Question(s)

Is positron emission tomography/computed tomography (PET/CT) beneficial in the diagnosis, staging, or clinical management of patients with suspected or proven sarcoidosis?

pdf download Summary (PDF) (40.01 KB)
pdf download Full Report (PDF) (74.11 KB)